Efficiency of Histidine-Associating Compounds for Blocking the Alzheimer's Aβ Channel Activity and Cytotoxicity

The opening of the Alzheimer's Aβ channel permits the flux of calcium into the cell, thus critically disturbing intracellular ion homeostasis. Peptide segments that include the characteristic histidine (His) diad, His13 and His14, efficiently block the Aβ channel activity, blocking Aβ cytotoxicity. We hypothesize that the vicinal His-His peptides coordinate with the rings of His in the mouth of the pore, thus blocking the flow of calcium ions through the channel, with consequent blocking of Aβ cytotoxicity. To test this hypothesis, we studied Aβ ion channel activity and cytotoxicity after the addition of compounds that are known to have His association capacity, such as Ni2+, imidazole, His, and a series of His-related compounds. All compounds were effective at blocking both Aβ channel and preventing Aβ cytotoxicity. The efficiency of protection of His-related compounds was correlated with the number of imidazole side chains in the blocker compounds. These data reinforce the premise that His residues within the Aβ channel sequence are in the pathway of ion flow. Additionally, the data confirm the contribution of the Aβ channel to the cytotoxicity of exogenous Aβ.